Adipose Tissue Selective Insulin Receptor Knockout Protects against Obesity and Obesity-Related Glucose Intolerance  by Blüher, Matthias et al.
Developmental Cell, Vol. 3, 25–38, July, 2002, Copyright 2002 by Cell Press
Adipose Tissue Selective Insulin Receptor Knockout
Protects against Obesity
and Obesity-Related Glucose Intolerance
insulin resistance, moderate glucose intolerance, and a
failure of insulin to suppress hepatic glucose production
and regulate hepatic gene expression (Michael et al.,
2000).
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In the present study, we investigated the physiologicalSummary
role of insulin signaling in adipose tissue by creating
fat-specific insulin receptor knockout (FIRKO) mice. WeInsulin signaling in adipose tissue plays an important
role in lipid storage and regulation of glucose homeo- find that FIRKO mice have markedly reduced fat mass
and whole-body triglyceride stores, and are protectedstasis. Using the Cre-loxP system, we created mice
with fat-specific disruption of the insulin receptor gene from gold thioglucose-induced and age-related obesity,
as well as the associated glucose intolerance. FIRKO(FIRKO mice). These mice have low fat mass, loss of
the normal relationship between plasma leptin and mice also exhibit a heterogeneity in fat cell size and
protein expression pattern, and inappropriately elevatedbody weight, and are protected against age-related
and hypothalamic lesion-induced obesity, and obe- leptin serum levels, suggesting previously unrecognized
roles of insulin in regulation of adipose tissue biology.sity-related glucose intolerance. FIRKO mice also ex-
hibit polarization of adipocytes into populations of
large and small cells, which differ in expression of fatty Results
acid synthase, C/EBP, and SREBP-1. Thus, insulin
signaling in adipocytes is critical for development of Creation and Molecular Characterization
obesity and its associated metabolic abnormalities, of Fat-Specific IR Knockout (FIRKO) Mice
and abrogation of insulin signaling in fat unmasks a Fat-specific insulin receptor knockout (FIRKO) mice
heterogeneity in adipocyte response in terms of gene were generated by breeding IR (lox/) mice (Bru¨ning et
expression and triglyceride storage. al., 1998) with transgenic mice that express the Cre
recombinase cDNA from the adipose-specific fatty acid
Introduction binding protein (aP2) promoter/enhancer (Ross et al.,
1990) as described in Experimental Procedures (Figure
Type 2 diabetes is characterized by insulin resistance in 1A). FIRKO mice were obtained with the expected Men-
muscle, liver, and fat, and by defects in insulin secretion delian frequency and exhibited normal growth until the
from the pancreatic  cell (Martin et al., 1992; Kahn, age of 8 weeks. Cre expression was restricted to white
1994). To define more precisely the role of each of these adipose tissue (WAT) and brown adipose tissue (BAT).
tissues in the pathogenesis of this disease, our labora- Efficiency and specificity of the IR knockout were ex-
tories and others have employed the Cre-loxP system amined in isolated adipocytes and tissue lysates from
(Gu et al., 1994) to create mice with tissue-specific control and FIRKO mice by immunoprecipitation with an
knockouts of the insulin receptor (Bru¨ning et al., 1998, IR-specific antiserum followed by Western blot analysis
2000; Kulkarni et al., 1999; Michael et al., 2000; Kahn with the same antiserum. IR expression was preserved
et al., 2000; Guerra et al., 2001), the GLUT4 glucose in skeletal muscle, liver, brain, heart, and other tissues
transporter (Abel et al., 1999, 2001; Zisman et al., 2000), examined (Figure 1D). IR expression was unaffected in
and glucokinase (Postic et al., 1999). Surprisingly, mus- isolated adipocytes in the brown (data not shown) and
cle-specific insulin receptor knockout (MIRKO) mice do white adipose tissue of WT, IR (lox/lox), and aP2-Cre
not show major defects in glucose metabolism (Bru¨ning mice, indicating that neither the loxP modification of
et al., 1998), whereas  cell-specific insulin receptor the IR locus nor expression of the aP2 transgene alone
knockout (IRKO) mice have impaired glucose tolerance affects IR expression. These genotypes, WT, IR (lox/
due to a selective loss of first phase glucose-stimulated lox), and aP2-Cre, had similar physiologic and metabolic
insulin secretion (Kulkarni et al., 1999). Moreover, liver- characteristics, and were considered controls. IR pro-
specific insulin receptor knockout (LIRKO) mice exhibit tein expression was reduced by 85%–99% in isolated
adipocytes of FIRKO mice. The remaining IR expression
could either be derived from vascular endothelial cells3 Correspondence: c.ronald.kahn@joslin.harvard.edu
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Figure 1. Transgene Construct, Assessment of Insulin Receptor Recombination, and Receptor Expression
(A) Representation of aP2-Cre transgene.
(B) Schematic representation of the IR lox allele before and after recombination. The position of the different primers used in the PCR analysis
is shown by the arrows labeled P1, P2, and P3. The knockout allele is shown below the floxed allele, indicating the deletion of exon 4 in the
event of recombination of the insulin receptor gene. B, BamHI; S, SalI; Sc, Sac1 restriction sites; NLS, nuclear localization signal.
(C) Results from PCR analysis of DNA prepared from isolated adipocytes. DNA from isolated adipocytes of FIRKO mice produced a 220 bp
band (lane 1) suggesting a recombination event; a 250 bp band was detected in WT mice (lane 2), and a 300 bp band, containing the loxP
site, was observed in adipocytes from IR lox mice (lane 3).
(D) Western blot analysis for insulin receptor  subunit of skeletal muscle, heart, liver, brain, brown adipose tissue (BAT), and white adipose
tissue (WAT) of four pooled control mice (upper panel) and eight pooled FIRKO mice (lower panel).
or stromal cells contaminating the isolated adipocytes To determine the consequence of reduced IR-medi-
ated signaling, basal and insulin-stimulated glucoseor be related to adipocytes, which escape aP2 expres-
sion. To assure uniformity of the FIRKO study groups, transport in isolated adipocytes from FIRKO mice and
control littermates was studied. In adipocytes fromIR recombination was assessed in WAT of each mouse
(see Experimental Procedures; Figure 1C), and only data FIRKO mice, basal glucose uptake is unchanged com-
pared to the controls, but insulin-stimulated glucosefrom mice with an efficient IR recombination were in-
cluded in the analysis. The tissue specificity and high uptake is reduced by90% at all insulin concentrations
from 0.05 nM to 100 nM (Figure 2A). The observed insulinefficiency of Cre activity were consistent with previous
studies in which the aP2-Cre mice were crossed with resistance in FIRKO adipocytes confirms the efficiency
of the adipocyte-specific IR knockout and is similar tothe ROSA26-lacZ reporter mouse (Abel et al., 2001; Zam-
browicz et al., 1997). that in mice with homozygous gene knockout of the
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insulin-sensitive glucose transporter GLUT4 (Abel et al., Despite the decreased whole-body fat mass, FIRKO
mice of both genders had about 25% higher plasma2001).
To assess lipolysis under the conditions of reduced leptin levels than control groups, although this differ-
ence was not statistically significant (Table 1). However,IR-mediated signaling (Figure 2B), white adipocytes
were isolated from epididymal fat pads and separated when expressed per mg of fat pad mass, plasma leptin
levels in FIRKO mice were 3-fold elevated (Figures 3Ainto two different groups based on adipocyte diameter
(small,75 m; large,75 m). Insulin inhibited isopro- and 3B), and the linear relationship between leptin levels
and body weight seen in the control groups was lostterenol-stimulated lipolysis in both adipocyte size
groups from control mice by 50% (p  0.02). By con- (Figure 3B), suggesting that adipose-specific IR knock-
out causes alterations in the leptin regulation.trast, there was no significant insulin inhibition of isopro-
terenol-stimulated lipolysis in FIRKO adipocytes (FIRKO Metabolic Parameters
To determine the physiological consequences of the fat-small, p  0.35; FIRKO large, p  0.07), although there
was a slight trend to lower levels. Moreover, basal glyc- specific IR knockout, we monitored body weight, blood
glucose concentration, and insulin levels in the fastederol release was significantly increased in large FIRKO
adipocytes, suggesting increased basal lipolysis in at and fed state, triglycerides, cholesterol, free fatty acids
(FFA), and leptin in plasma, and performed serial glucoseleast this subset of adipocytes from FIRKO mice.
To determine the consequence of adipocyte-specific and insulin tolerance testing over an age range from 2
to 10 months. Fasted and fed glucose concentrationsIR knockout on lipogenesis and glucose metabolism,
we measured glucose metabolism in the three major were indistinguishable between FIRKO mice and control
littermates at 2–8 months (Table 1). Although there wasmetabolic pathways—triglycerides, CO2, and lactate—at
5 mM glucose in the absence and presence of 80 nM no significant difference in plasma-fed insulin concen-
trations, FIRKO mice showed significantly lower fastedinsulin (Figure 2C). Insulin stimulated a 2- to 3-fold in-
crease into all three pathways in WT adipocytes of two insulin concentrations compared to WT and aP2-Cre
mice (p  0.05; Table 1). Serum IGF-1 concentrationsdifferent diameter groups (small, 75 m; large, 75
m), whereas insulin had no effect on large and small were indistinguishable between FIRKO mice and control
littermates at the age of 2 and 10 months (FIRKO, 136adipocytes from FIRKO mice. In the basal state, glucose
incorporation into triglycerides was increased in large 42 nmol/l; controls, 127 34 nmol/l). Serum triglyceride
levels were significantly reduced in FIRKO mice com-FIRKO adipocytes as compared to the other groups (p
0.05). Basal and insulin-stimulated glucose metabolism pared to WT and IR (lox/lox) mice (Table 1), whereas
serum FFA, plasma leptin (Table 1), and cholesterol (Ta-in all three pathways was significantly reduced in small
FIRKO adipocytes as compared to all other groups (p ble 1) as well as lactate levels were not significantly
different among the groups. The serum concentration0.05). In WT adipocytes,30% of glucose was incorpo-
rated into triglycerides, 15% of glucose was incorpo- of the 30 kDa adipocyte complement-related protein
(ACRP30) was significantly increased in FIRKO mice atrated into CO2, and 55% was metabolized to lactate.
In large and small FIRKO adipocytes, 50% of the glu- the age of 10 months as compared to control littermates
(25.7  4.4 ng/ml versus 16.3  3.1 ng/ml; p  0.05).cose is incorporated into triglycerides, and the amount
of glucose metabolized into lactate was significantly Likewise, intraperitoneal glucose tolerance testing
(GTT) performed on 2-month-old male FIRKO and con-lower in both subsets of FIRKO adipocytes as compared
to small and large WT control cells. trol mice demonstrated normal glucose tolerance in all
groups (Figure 4A). However, by the age of 10 months,
all control groups showed impaired glucose tolerancePhysiological Consequence of Fat-Specific
due to increasing insulin resistance associated withIR Knockout
aging, whereas FIRKO mice maintained normal glucoseBody Fat Is Markedly Reduced in FIRKO Mice
tolerance (Figure 4B). Intraperitoneal insulin toleranceGrowth curves were normal in male and female FIRKO
tests (ITT) at 2 months of age in male mice were indistin-mice from birth to 4 weeks of age (data not shown). By
guishable between FIRKO and control mice (Figure 4C).8 weeks of age, however, FIRKO mice had gained less
Insulin resistance increased by 10 months of age in allweight than control group littermates (Figure 2D). In ad-
control groups, but not in FIRKO mice (Figure 4D).dition, perigonadal fat pad mass (Figure 2E), intrascapu-
lar brown fat pad mass (2.77  0.15 mg/g body weight
in the controls versus 1.21  0.12 mg/g body weight in FIRKO Mice Are Protected from Gold
Thioglucose-Induced ObesityFIRKO mice at the age of 3 months), and whole-body
triglyceride content was significantly lower in FIRKO and Glucose Intolerance
Gold thioglucose (GTG) treatment results in specific le-mice compared to the control groups (Figure 2F). The
reduced adipose tissue mass was not related to a de- sions in the ventromedial hypothalamus with subse-
quent development of hyperphagia and obesity (Debonscrease of the total number of adipocytes in FIRKO mice.
The number of adipocytes per perigonadal fat pad was et al., 1977). To assess the impact of this hyperphagia in
this model, 4-week-old FIRKO mice and their littermatesnot significantly different between FIRKO (4.13 0.18
106 cells) and control (3.97  0.24  106 cells) mice. were treated with either 0.5 mg/g body weight GTG or
normal saline (control group), and body weight and foodDespite the 50% reduction in BAT mass, the expres-
sion of UCP-1, at both the mRNA and protein level, was intake were obtained before and 12 weeks after treat-
ment. In both FIRKO and control mice, daily food intakeindistinguishable between BAT from FIRKO mice and
controls; when expressed per mg of BAT mass, UCP-1 increased 2- to 3-fold after GTG treatment as com-
pared to saline-treated mice (Figure 5A). As a result,expression (both mRNA and protein) was increased in
BAT of FIRKO mice (data not shown). there was a 60%–100% increase in weight gained and
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Figure 2. Glucose Uptake and Lipolysis in Isolated Adipocytes, Glucose Metabolism into Different Pathways, Body Weight, Gonadal Fat Pad
Mass, and Whole-Body Triglyceride Stores in FIRKO Mice and Controls
(A) Dose-response curves for insulin-stimulated U-[14C]glucose uptake in isolated adipocytes from 3-month-old male FIRKO mice (n  6) and
WT, IR lox, and aP2-Cre control littermates (n  16). Values at insulin concentrations of 0.05 nM and higher are significantly different between
FIRKO mice and controls (* p  0.05).
(B) Lipolysis in isolated adipocytes. Adipocytes were isolated from epididymal fat pads of 4-month-old WT (pooled from four animals) and
FIRKO (pooled from eight animals) mice, separated into two different subsets using a nylon mesh of 75 m pore size (small adipocytes,
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Table 1. Metabolic Parameters in 2- and 10-Month-Old Male FIRKO and Control Mice (n  25 per Group)
WT aP2-Cre IR (lox/lox) FIRKO
Fasted glucose (mg/dl) 56  2 54  3 58  5 57  6
73  5 68  7 65  5 60  4
Fasted insulin (pg/ml) 260  39 232  30 222  66 151  21a
298  45 275  27 267  15 207  41a
Fed glucose (mg/dl) 147  3 148  11 135  7 141  9
197  15 168  17 179  13 156  14
Fed insulin (pg/ml) 1367  239 1334  202 1265  150 1349  219
1513  350 1668  272 1497  216 1574  308
Triglycerides (mg/dl) 170  26 142  13 177  28 129  19b
173  25 168  17 185  9 165  12
Cholesterol (mg/dl) 131  28 127  18 119  22 108  17
145  15 135  17 144  17 123  14
FFAs (mEq/L) 1138  89 1278  83 1157  114 1054  145
1035  75 1115  82 1314  101 1487  152
Leptin (pg/ml) 577  163 723  167 811  232 1010  360
1236  204 1087  205 1212  250 1376  278
Numbers in italics indicate the values in 10-month-old mice.
a Significant differences from WT and aP2-Cre mice.
b Significant differences from WT and IR (lox/lox) mice, p  0.05.
in the development of obesity in WT, IR (lox/lox), and on the WAT of FIRKO and control mice. At 2 months
of age, fat pads from FIRKO mice contained a mixedaP2-Cre mice. Remarkably, despite the hyperphagia,
FIRKO mice treated with GTG had weight gain compara- population of large and small adipocytes as compared
to the relatively uniform adipocyte size in WAT from WT,ble to that observed in their saline-treated littermates
(Figure 5B). Serum leptin levels increased in all GTG- IR (lox/lox), and aP2-Cre mice (Figure 6A). Quantitation
of these histologic sections revealed a polarization oftreated mice, but were significantly lower in the GTG-
treated FIRKOs as compared to the GTG-treated con- adipocytes into two major groups in FIRKO mice: small
cells with a diameter  75 m and large cells with atrols (Figure 3C). Moreover, intraperitoneal glucose
tolerance testing performed 12 weeks after GTG treat- diameter  100 m with only 7.6  1.3% of the cells in
the size range of 75–100 m (Figure 6C). For WT mice,ment demonstrated normal glucose tolerance in FIRKO
mice, whereas all of the control groups had developed there was a normal distribution of cell size with the major
fraction (26.7  2.8%) being in the range of 75–100 msignificantly impaired glucose tolerance (Figure 5C). In-
sulin sensitivity, as determined by insulin tolerance test- (Figure 6B). This polarization of cell size was confirmed
by FACS analysis of osmic acid-fixed isolated adipo-ing, also remained normal in FIRKO mice after GTG
treatment, whereas WT, IR (lox/lox), and aP2-Cre mice cytes, which revealed a significant increase in the per-
centage of small adipocytes, that is, cells with a diameterdisplayed marked insulin resistance (Figure 5D). There
was no increase in lipid accumulation in the livers of of less than 75 m, in FIRKO mice (46.4  4.3% of total
cell number) as compared to those in fat pads of WTFIRKO mice after GTG treatment. Thus, the adipose-
specific IR knockout in FIRKO mice protects from GTG- mice (29.8  2.6% of total cell number; p  0.05; data
not shown).induced, as well as age-related, obesity and obesity-
related glucose intolerance and insulin resistance. To further characterize these different sized adipo-
cytes, cells were fractionated by filtering the adipocyte
suspension through nylon mesh screens of differentIR Knockout in Adipose Tissue Causes
a Polarization in Adipocyte Size pore size, and analyzed with respect to glucose uptake
and expression of several key regulatory proteins. Aswith Differences in Protein Expression
To evaluate the impact of loss of the IR on adipose compared to controls, IR expression in both large and
small adipocytes of FIRKO mice was reduced by 85%–tissue morphology, we carried out histological studies
diameter  75 m and large adipocytes, diameter  75 m from both genotypes) and then assayed for glycerol release over 20 min as
an indicator of lipolysis. Lipolysis assays were performed in the presence of adenosine deaminase and 10 M PIA (N6-[R-(-)-1-methyl-2-
phenyl]adenosine). 100 M isoproterenol was used to produce maximal increase of lipolysis. Inhibition of isoproterenol-stimulated glycerol
release by 100 nM insulin was measured. Results are expressed as pmol of glycerol released per cell during 20 min (mean of five experiments).
a: significant difference between insulin 100 nM and 100 M isoproterenol versus 100 M isoproterenol, p  0.02; b: significant difference
between basal from FIRKO large versus all other groups, p  0.05. ns, not significant.
(C) Lipogenesis assays. Glucose metabolism into triglycerides, CO2, and lactate was measured at 5 mM glucose in isolated adipocytes from
4-month-old wild-type and FIRKO mice after 2 hr incubation in the absence (basal) or presence of 80 nM insulin. Each experiment was carried
out on pooled adipocytes from four to six FIRKO and two to four WT mice separated into two different size groups (small, diameter  75 m;
large, diameter  75 m). Values are means  SEM of at least three separate experiments. The asterisk indicates significant difference from
basal, p  0.01; a: significant difference between FIRKO large basal and all other groups basal, p  0.05; b: significant difference between
FIRKO small basal and all other groups basal, p  0.05.
(D–F) Body weight (D), gonadal fat pad mass (E), and whole-body triglyceride (F) stores in FIRKO mice and controls (WT, aP2-Cre, and IR
[lox/lox]) determined using 4-month-old males. Each bar represents the mean  SEM of 12 animals of each genotype for body weight and
fat pad mass and six animals for the triglyceride content. ns, not significant. The asterisks indicate p  0.05.
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Figure 3. Altered Relationship between
Plasma Leptin Levels and Body Weight or
Gonadal Fat Pad Mass in FIRKO Mice
Plasma leptin levels were measured in tripli-
cate using an ELISA assay.
In (A) it is shown that FIRKO mice had signifi-
cantly (p  0.05) higher plasma leptin levels
in relation to gonadal fat pad mass compared
to control littermates. Data represent the
mean  SEM of 15 animals per genotype
(*p  0.05). In (B), plasma leptin levels are
expressed in relation to body weight (g) in
2-month-old male FIRKO mice and control
littermates. In WT, aP2-Cre, and IR (lox/lox)
mice, plasma leptin levels correlated with
body weight (r  0.732, p  0.05), whereas
leptin levels for the FIRKO mice (filled circles)
were not related to body mass. Data repre-
sent the meanSEM of at least eight animals
per genotype.
99%, indicating that the heterogeneity was not due to adipocytes as compared to controls; (3) differential lev-
els in large and small FIRKO adipocytes; and (4) un-differences in efficiency of gene recombination in the
small and large cells (see Figure 7A). This was confirmed changed levels in FIRKO cells as compared to the con-
trol groups. The first pattern, that is, decreased levelsby PCR analysis of small and large adipocytes of FIRKO
mice (data not shown). Basal glucose uptake in WT in both large and small FIRKO cells, was observed for
the insulin receptor (Figure 7A) and the GLUT1 glucoseadipocytes decreased slightly with increasing adipocyte
size, and became significant in adipocytes with a transporter (Figure 7B). The former was expected based
on the knockout efficiency. The latter indicated that nor-diameter  150 m. As previously observed (Foley et
al., 1980), smaller adipocytes (diameter  100 m) from mal insulin action is crucial for GLUT1 protein expres-
sion in vivo. The second pattern, or increased levels incontrol mice were also significantly more responsive to
insulin than large adipocytes (diameter  100 m) in both large and small FIRKO cells, was observed for 30
kDa adipocyte complement-related protein (ACRP30;terms of insulin-stimulated glucose uptake (Figure 6E).
In FIRKO mice, basal glucose uptake in adipocytes was Figure 7C). This 50%–60% increase in ACRP30 protein
levels is in accordance with significantly increasednot different among the cell size fractions (Figure 6D),
and there was a lack of insulin-stimulated glucose trans- ACRP30 serum concentrations in FIRKO mice as com-
pared to controls (see above). The third pattern of ex-port in any cell size range, confirming the insulin receptor
was knocked out in all adipose cell size groups. pression with differential expression between large and
small cells was observed for the adipogenic transcrip-To examine some potential differences between the
small (75 m) and large (75 m) adipocytes from tion factors SREBP-1 (Figure 7D) and C/EBP	 (Figure
7E), both of which were reduced in FIRKO adipocytesFIRKO mice, we measured the expression of several
key adipocyte proteins that might be regulated in re- as compared to adipocytes from controls, but were more
markedly decreased in the small FIRKO adipocytes thansponse to the IR knockout. Four different patterns of
expression were observed: (1) decreased levels in both the large FIRKO adipocytes. This differential pattern of
expression was also observed for the levels of fatty acidlarge and small FIRKO adipocytes as compared to con-
trols; (2) increased levels in both large and small FIRKO synthase (FAS); however, in this case, levels in large
Consequences of Adipose Insulin Receptor Knockout
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Figure 4. FIRKO Mice Are Protected from Age-Related Glucose Intolerance and Insulin Resistance
(A and B) Shown are glucose tolerance tests performed on 2-month-old (A) and 10-month-old (B) male WT, IR (lox/lox), aP2-Cre, and FIRKO
mice as described in Experimental Procedures. Results are expressed as mean  SEM from at least eight animals per genotype. Values at
15, 30, 60, and 120 min are significantly different between FIRKO mice and controls (WT, IR [lox/lox], aP2-Cre; *p  0.05).
(C and D) Shown are insulin tolerance tests, performed on random-fed, 2-month-old (C) and 10-month-old (D) male WT, IR (lox/lox), aP2-Cre,
and FIRKO mice as described in Experimental Procedures. Results are expressed as mean percent of basal blood glucose concentration 
SEM for at least eight animals per genotype. In (D), values at 30 and 60 min are significantly different between FIRKO mice and controls (WT,
IR [lox/lox], aP2-Cre; *p  0.05).
cells were indistinguishable from those in controls, and indirect effects in almost all tissues of the body. Tissue-
specific disruption of insulin signaling has provided aonly the small FIRKO adipocytes had significantly re-
duced expression (Figure 7F). The final pattern of ex- powerful approach to dissect these complex and inter-
acting pathways and to sort out direct and indirect ef-pression, that is, no change in amount in either large or
small FIRKO adipocytes (see Supplemental Figures S1A– fects of the hormone (Michael et al., 2000). It has been
suggested that skeletal muscle accounts for 70%–90%S1F at http//www.developmentalcell.com/cgi/content/
full/3/1/25/DC1), was observed for the GLUT4 glucose of glucose disposal following a carbohydrate load (De-
Fronzo, 1997), but the fraction of insulin-stimulated glu-transporter (Supplemental Figure S1A), the adipogenic
transcription factor PPAR
 (Supplemental Figure S1B), cose uptake in adipose tissue increases with duration
of insulin elevation (James et al., 1985; Livingston etthe fatty acid binding protein aP2 (Supplemental Figure
S1C), leptin protein (Supplemental Figure S1D), and the al., 1978). Fat clearly plays an important role in overall
insulin receptor substrates IRS-1 and IRS-2 (Supple- glucose homeostasis, however, as indicated by the insu-
mental Figures S1E and S1F). There was also no signifi- lin resistance associated with obesity (Kopelman, 2000)
cant difference in the levels of any of the analyzed pro- and various syndromes of lipodystrophy (Joffe et al.,
teins between small and large adipocyte fractions from 2001), and the insulin resistance observed in mice with
the three control groups WT, IR (lox/lox), and aP2-Cre a fat-specific knockout of GLUT4 (Abel et al., 2001).
mice (data not shown). In this study, we demonstrated that adipocyte-spe-
cific inactivation of the insulin receptor gene in FIRKO
Discussion mice produces selective insulin resistance in the adi-
pose tissue, but does not affect whole-body glucose
metabolism. More importantly, lack of insulin receptorInsulin is an essential regulator of intermediary metabo-
lism and produces a broad spectrum of both direct and in fat produces almost complete protection against age-
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Figure 5. Effect of Gold Thioglucose (GTG) on FIRKO Mice
Male FIRKO mice and controls were given 0.5 mg/g body weight GTG at 4 weeks of age.
(A) Food intake was determined daily over a week before and 12 weeks after GTG injection. Data represent the mean  SEM of at least eight
animals per genotype. The daily food intake increased by 125% in FIRKO and control littermates after GTG treatment (p  0.05).
(B) Shown is the body weight gain 12 weeks after GTG (male, initial dose at 4 weeks) or saline treatment in FIRKO and control mice. There
was no significant difference in the initial weight at 4 weeks between all genotypes. Despite the increased food intake after GTG treatment,
FIRKO mice were protected from the increase in body weight in GTG-treated controls compared to the saline group (*p  0.05).
(C) Plasma leptin levels at 12 weeks after GTG (male, initial dose at 4 weeks) or saline treatment in FIRKO and control mice are plotted. The
increase in plasma leptin levels after GTG-induced obesity and hyperphagia in all genotypes was significantly lower in FIRKO mice compared
to controls (*p  0.05).
(D) Glucose tolerance tests, 12 weeks after GTG-induced obesity in FIRKO mice and control littermates. Values at all time points were
significantly different between FIRKO mice and controls (WT, IR [lox/lox], aP2-Cre; *p  0.05).
(E) Insulin tolerance tests, 12 weeks after GTG-induced obesity in FIRKO mice and control littermates. Values at 30 and 60 min were significantly
different between FIRKO mice and controls (WT, IR [lox/lox], aP2-Cre; *p  0.05).
Consequences of Adipose Insulin Receptor Knockout
33
Figure 6. White Adipose Tissue of FIRKO Mice Displays Heterogeneity in Cell Size and Impairment of Insulin-Stimulated Glucose Uptake
(A) Hematoxylin and eosin staining of white adipose tissue sections from random-fed, 4-month-old male FIRKO and WT mice. Initial magnifica-
tion, 40.
(B) The distribution curve of diameter for 100 measured fat cells per slide shows a bimodal distribution in adipocytes of FIRKO mice with two
peaks (small adipocytes, diameter 25–75 m and large adipocytes, diameter 100–150 m).
(C) The diameter distribution curve for controls showed a normal distribution. Data represent the mean  SEM of ten slides from six mice.
(D) Adipocytes from epigonadal fat pads of four WT and eight FIRKO 3-month-old male mice were isolated, pooled, and then separated into
different diameter ranges as described in Experimental Procedures. Insulin stimulation was performed for 30 min at 100 nM. Data represent
the mean  SEM of five independent experiments.
(E) Basal and insulin-stimulated glucose uptake in adipocytes from 3-month-old male WT mice.
and hyperphagia-associated obesity and the impair- phenotype of FIRKO and adipose-specific GLUT4
knockout mice may be explained by the fact that, inment of glucose tolerance associated with these condi-
tions. This is quite distinct from the phenotype of the addition to the regulation of glucose transport, insulin
has other important actions in adipose tissue, such asadipocyte selective reduction of glucose transporter
GLUT4, which results in glucose intolerance, hyperinsu- stimulation of lipogenesis, inhibition of lipolysis, and
regulation of ACRP30 secretion, and these were alsolinemia, and insulin resistance without an effect on adi-
pose mass (Abel et al., 2001). The differences in the lost in adipocytes of FIRKO mice. These differences
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Figure 7. Differential Protein Expression in Isolated Adipocytes from 3-Month-Old Male WT, aP2-Cre, IR (lox/lox), and FIRKO Mice
Adipocytes from epididymal fat pads of four WT and eight FIRKO mice were isolated by collagenase digestion, pooled, and separated into
two different subsets using a nylon mesh of 75 m pore size. There was no difference in the expression of proteins between the two cell size
subsets in adipocytes from the control mice (WT, IR [lox/lox], and aP2-Cre; data not shown). Therefore, only the FIRKO adipocytes are divided
into large (FIRKO L, adipocytes with a diameter  75 m) and small (FIRKO S, adipocytes with a diameter  75 m) subsets in the figure
shown. A representative Western blot and the data  SEM from four independent experiments are shown for the insulin receptor (A), GLUT1
(B), ACRP30 (C), SREBP-1 (D), C/EBP	 (E), and FAS (F).
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between the whole-body glucose metabolism of the adi- fractions are differentially affected by the IR knockout.
The subset of small adipocytes (45% of the cells) ispose tissue-specific IR and GLUT4 knockout mice, as
well as the differences observed between the muscle- protected from excessive TG load, whereas a second
subset of FIRKO adipocytes maintains normal TG stor-specific IR (Bru¨ning et al., 1998) and GLUT4 (Zisman et
al., 2000) knockout mice further suggest that the step age function, despite the loss of insulin action on both
lipogenesis and antilipolysis. This was confirmed byin the insulin action cascade at which insulin resistance
is induced even in a single tissue can contribute to major measurements of the glucose metabolism in isolated
adipocytes. Thus, it appears that knockout of the insulindifferences in phenotype. Interestingly, FIRKO mice, in
which the IR is disrupted both in WAT and in BAT, also receptor may unmask an intrinsic heterogeneity in adi-
pocytes and that protection from excessive TG load indisplay a different phenotype from the brown adipose
tissue-specific insulin receptor knockout mice (BAT- only a fraction of adipocytes is sufficient to protect
FIRKO mice from development of obesity and its relatedIRKO; Guerra et al., 2001). The latter exhibit an age-
dependent impaired glucose tolerance without insulin effects on glucose intolerance and insulin resistance.
The development of the small and large subsets ofresistance, and this seems to be the primary result of a
defect in insulin secretion. This suggests that the knock- FIRKO adipocytes was not due to inefficiency of the IR
knockout. Likewise, there were no differences in theout of the insulin receptor in WAT has a protective effect
over the glucose metabolism impairing effects of the IR expression of the IRS proteins or the GLUT4 or GLUT1
glucose transporters, or in insulin-stimulated glucoseknockout in BAT of BATIRKO mice, perhaps by altering
one or more of the factors secreted by WAT. uptake into adipocytes between small and large FIRKO
cells. Thus, differences in insulin signaling or glucoseOur data further show that insulin signaling in adipo-
cytes is crucial for triglyceride storage and the develop- transport cannot explain the heterogeneity of the adipo-
cyte size. One explanation for the heterogeneity in fatment of obesity and its associated metabolic abnormali-
ties. These insulin effects may be mediated by factors cell size of FIRKO mice might be that lipogenesis, lipoly-
sis, and extent of differentiation are some how differen-other than the impaired glucose transport in adipocytes,
since fat-specific GLUT4 knockout mice have normal tially regulated in these adipocyte size fractions. This
hypothesis is supported by the results from the directbody weight, perigonadal fat pad weight, and mean adi-
pocyte size (Abel et al., 2001). The protection from obe- assessment of lipogenesis and lipolysis in isolated adi-
pocytes and by the observation that fatty acid synthasesity in FIRKO mice, despite the increased food intake
relative to their body weight, could be explained by lack and the adipogenic transcription factors SREBP-1 and
C/EBP	 are expressed at lower levels in the small adipo-of the permissive effect of insulin on triglyceride storage
in fat or by lack of the antilipolytic effects of insulin in cytes as compared to the large adipocytes of the FIRKO
mice. This heterogeneity might also represent differentadipocytes. Although plasma FFA, triglyceride (TG), and
lactate levels are not elevated in FIRKO mice, this does stages of adipocyte differentiation, although there were
no differences in the protein levels of the adipogenesisnot preclude a small increase in adipocyte triglyceride
turnover. Indeed, basal lipolysis and basal lipogenesis markers PPAR
, GLUT4, and the adipocyte fatty acid
binding protein aP2, all features of terminally differenti-were increased in the subset of large adipocytes from
FIRKO mice. The subset of small adipocytes, on the ated adipocytes. The differential protein expression pat-
terns of SREBP-1, C/EBP	, and FAS in small and largeother hand, showed markedly decreased lipogenesis,
which seems to be the likely cause of the lean phenotype FIRKO adipocytes might display a different susceptibil-
ity of these proteins to insulin regulation in differentof FIRKO mice. The resistance to obesity despite GTG-
induced hyperphagia and the relative increase in UCP-1 subsets of adipocytes or that differences in the timing
of the IR knockout cause these differences in proteinexpression in BAT of FIRKO mice also suggest that
metabolic rate is increased in FIRKO mice. By analogy expression. Further studies are necessary to elucidate
the underlying mechanisms for the heterogeneity of theto the BATIRKO mice, this may be the result of an in-
crease in the thermogenic capacity of the BAT that con- protein expression patterns in the different adipocyte
size fractions in FIRKO adipose tissue.tributes to the lean phenotype in FIRKO mice (Guerra
et al., 2001). FIRKO mice provide a novel model for investigating
the role of insulin in the regulation of leptin secretionAnother surprising finding was the effect of the lack
of insulin signaling in adipose tissue on morphology from adipose tissue in vivo. Since plasma leptin levels
are normally proportional to adipose tissue mass (Maffeiand protein expression in WAT. There was a marked
reduction in GLUT1, but not in GLUT4, protein level in et al., 1995), we expected that FIRKO mice with a50%
decrease in adipose tissue mass would have proportion-adipose tissue from FIRKO mice, indicating GLUT1 ex-
pression is directly insulin regulated, whereas factors ally decreased plasma leptin levels. Despite the de-
creased body fat mass, however, plasma leptin levelsother than insulin are more important in the regulation
of GLUT4 levels in vivo. This observation is in accor- are normal or slightly elevated in FIRKO mice, and mark-
edly elevated when expressed as a function of bodydance with in vitro data showing that insulin selectively
increases the amount of GLUT1 (Hajduch et al., 1992) weight or fat mass. This finding is even more surprising,
since a lack of insulin signaling in adipocytes of FIRKOin 3T3-L1 adipocytes without altering the GLUT4 expres-
sion and that dexamethasone-induced insulin resis- mice would be expected to lead to decreased plasma
leptin levels, as both in vitro and clinical studies indicatetance in these cells also acts primarily by causing a
decrease in GLUT1 protein expression (Sakoda et al., that insulin stimulates leptin expression and secretion
(D’Adamo et al., 1998; Bradley and Cheatham, 1999;2000).
The heterogeneity of adipocyte size in white adipose Glasow et al., 2001). There is evidence for an interaction
between leptin and insulin signaling pathways in vitrotissue in FIRKO mice suggests that specific adipocyte
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mesh screens with pore sizes of 25, 75, 100, 150, and 400 m(Szanto and Kahn, 2000; Zhao et al., 2000), and reduced
(Etherton et al., 1981). Aliquots of adipocytes were fixed with osmicglucose uptake in rat adipocytes has been shown to
acid and counted in a Coulter counter (Cushman and Salans, 1978).be associated with decreased leptin secretion in vitro
Adipocyte size was determined by dividing the lipid content of the
(Mueller et al., 1998). However, our results in FIRKO mice cell suspension by the cell number (Cushman and Salans, 1978).
confirm the previous finding in adipose selective GLUT4 For the determination of glucose transport, isolated adipocytes of
different diameters were stimulated with 100 nM insulin for 30 minknockout mice that normal glucose uptake into adipo-
and then incubated for 30 min with 3 M U-[14C]glucose (Tozzo etcytes is not necessary to maintain normal plasma leptin
al., 1997). Immediately after the incubation adipocytes were fixedlevels (Abel et al., 2001). Our results also indicate that
with osmic acid, incubated for 48 hr at 37 (Etherton et al., 1977), and
the role of insulin in the regulation of leptin secretion is the radioactivity was quantified after the cells had been decolorized.
more complex than originally believed. For analysis of lipolysis, isolated adipocytes (100 l of a 10%
FIRKO mice also provide a model for investigating the isolated fat cell suspension) were incubated in the presence of aden-
osine deaminase and 10M PIA (N6-[R-(-)-1-methyl-2-phenyl]aden-role of insulin in the regulation of ACRP30 secretion
osine; basal), with 100 M isoproterenol to produce maximal in-from adipocytes in vivo. ACRP30 is the most abundant
crease of lipolysis for 20 min and with 100 nM insulin, 15 min priorsecretory protein in adipocytes and has been shown to
to the addition of 100 M isoproterenol. Glycerol content of the
enhance insulin sensitivity in normal and insulin-resis- incubation medium was determined after 20 min (Tozzo et al., 1995)
tant mice (Yamauchi et al., 2001; Berg et al., 2001). In using a radiometric assay as previously described (Susulic et al.,
1995).accordance with recent in vitro studies suggesting that
For the assessment of lipogenesis, glucose metabolism into threeinsulin is a negative regulator of ACRP30 expression in
different pathways was determined at 5 mM glucose (containingadipocytes (Fasshauer et al., 2002), we found elevated
3 M U-[14C]glucose) using a 10% isolated fat cell suspension. Glu-
ACRP30 protein expression in adipocytes and elevated cose incorporated into triglycerides and CO2 was measured after 1
ACRP30 serum concentrations in FIRKO mice. In- hr incubation in the absence or presence of 80 nM insulin as de-
creased ACRP30 secretion could help compensate for scribed (Tozzo et al., 1995). Glucose incorporated into lactate was
measured after 1 hr incubation and after separation of lactate fromthe adipocyte-specific insulin resistance in FIRKO mice
glucose using anion exchange columns (AG1-X8 resin, Bio-Rad).and could therefore explain, at least in part, the pheno-
type of FIRKO mice with normal insulin sensitivity and Immunoprecipitations and Western Blot Analysis
normal glucose homeostasis. Tissues were removed and homogenized as previously described
(Michael et al., 2000). Immunoprecipitations and Western blot analy-
Experimental Procedures ses were performed on homogenates from isolated adipocytes. For
each determination, cells were pooled from four WT, IR (lox/lox),
Animals and Genotyping and aP2-Cre mice or eight FIRKO mice, respectively. FIRKO mice
were used only after confirmation of efficient insulin receptor knock-IR (lox/lox) mice derived from 129Sv and C57Bl/6 chimeras were
out by IR rearrangement PCR (see above). For the analysis of insulincreated by homologous recombination using an insulin receptor
receptor expression, protein extracts from white and brown adiposegene targeting vector with loxP sites flanking exon 4 as previously
tissue, liver, skeletal muscle, heart, and brain (Figure 1D) were sub-described (Bru¨ning et al., 1998). FVB mice carrying the aP2-Cre
jected to immunoprecipitation using insulin receptor-specific anti-transgene were made by cloning a 1.4 kb SacI/SalI complementary
sera followed by Western blot analysis with the same antibody (ArakiDNA fragment encoding Cre recombinase, modified by inclusion of
et al., 1994). At least three blots of samples from four (controls)a nuclear localization sequence (NLS) and a consensus polyadenyla-
to eight animals (FIRKO) of each genotype were scanned using ation signal, immediately downstream of the 5.4 kb promoter/
Molecular Dynamics Storm PhosphoImager, and signals were quan-enhancer of fatty acid binding protein aP2 (Abel et al., 2001; Figure
tified using ImageQuant version 4.0 software. Statistical analysis of1A). Adipose tissue or fat-specific insulin receptor knockout mice
the data was performed using a two-tailed unpaired t test, and(FIRKO) were derived by crossing double-heterozygous IR (lox/)
significance was rejected at p  0.05.with IR (lox/) mice that also expressed Cre recombinase under
the control of the aP2 promoter/enhancer (aP2-Cre-IR [lox/]).
Analytical ProceduresAnimals were housed in virus-free facilities on a 12 hr light/dark
Blood glucose values were determined using whole venous bloodcycle (0700 on, 1900 off) and were fed a standard rodent chow
and an automatic glucose monitor (Glucometer, Bayer). Serum insu-(mouse diet 9F, PMI Nutrition International) and water ad libitum.
lin levels were measured by ELISA using mouse insulin as a standardAll protocols for animal use and euthanasia were reviewed and
(Crystal Chem.). Serum triglyceride levels were measured in fastedapproved by the Animal Care Committee of the Joslin Diabetes
animals by colorimetric enzyme assay using the GPO-Trinder assayCenter and were in accordance with NIH guidelines. Genotyping
(Sigma). Serum-free fatty acid levels were analyzed on fasted ani-was performed by PCR using genomic DNA isolated from the tail
mals using the NEFA-Kit-U (Wako Chemicals GmBH) with oleic acidtip as previously described (Bru¨ning et al., 1998). The 5 and 3
as a standard. Serum IGF-1 levels were analyzed using a rat IGF-1primers for the Cre transgene were 5-ATG TCC AAT TTA CTG ACC
RIA (DSLaboratories); adiponectin (ACRP30) serum levels were
G-3 and 5-CGC CGC ATA ACC AGT GAA AC-3 and for the IR lox
measured using a mouse adiponectin RIA kit (Linco Research).
gene were 5-GAT GTG CAC CCC ATG TCT G-3 and 5-CTG AAT
Plasma leptin was measured using the rat leptin RIA kit (Linco Re-
AGC TGA GAC CAC AG-3. The assessment of insulin receptor search).
recombination was performed with DNA from isolated adipocytes Glucose tolerance tests were performed on animals that had been
of each animal using a previously described PCR strategy (Kulkarni fasted overnight for 16 hr, whereas insulin tolerance tests were
et al., 1999; Figure 1B) in which a 250 bp amplified product indicated performed in the fed state at 14 hr. Animals were injected with either
an intact exon 4, a 220 bp product suggested the presence of Cre- 2 g/kg body weight of glucose or 1 U/kg body weight of human
mediated recombination, and a 300 bp product represented insulin regular insulin (Eli Lilly) into the peritoneal cavity. Glucose levels
receptor genes with an intact exon 4 flanked by a loxP site were measured from blood collected from the tail immediately be-
(Figure 1C). fore and 15, 30, 60, and 120 min after the injection. Body lipid
(triglyceride) content of six mice from each genotype was deter-
Isolation of Adipocytes, Adipocyte Size, Glucose Transport, mined by enzymatic measurement of glycerol after digestion of the
and Glucose Metabolism Studies carcass in 3 M ethanolic KOH (Sigma) for 7 days at 60C.
Animals were sacrificed, and periovarian or epididymal fat pads
were removed. Adipocytes were isolated by collagenase (1 mg/ml) Gold Thioglucose Treatment
digestion. Separation of cells into different diameter fractions was At least eight 4-week-old male mice from each genotype were in-
jected intraperitoneally with either a single dose of 0.5 mg/g bodyachieved by filtering the adipocyte suspension through serial nylon
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weight GTG (Fluka) in normal saline or normal saline (control ani- Orban, P.C., Klein, R., Krone, W., Mu¨ller-Wieland, D., and Kahn, C.R.
(2000). Role of brain insulin receptor in control of body weight andmals). Food intake of 4-week-old male FIRKO and control littermates
was determined daily over a week before and 12 weeks after gold reproduction. Science 289, 2122–2125.
thioglucose (GTG) or saline injection. Body weight was determined Cushman, S.W., and Salans, L.B. (1978). Determinations of adipose
at least once per week, and 12 weeks after the GTG injection, glu- cell size and number in suspension of isolated rat and human adi-
cose and insulin tolerance tests were performed in addition to me- pose cells. J. Lipid Res. 19, 269–273.
tabolite measurements.
D’Adamo, M., Buongiorno, A., Maroccia, E., Leonetti, F., Barbetti,
F., Giaccari, A., Zoretta, D., Tamburrano, G., and Sbraccia, P. (1998).
Histology Increased OB gene expression leads to elevated plasma leptin con-
Tissues were fixed in 10% buffered formalin and imbedded in paraf- centrations in patients with chronic primary hyperinsulinemia. Dia-
fin. Multiple sections (separated by 70–80 m each) were obtained betes 47, 1625–1629.
from gonadal fat pads and analyzed systematically with respect to
Debons, A.F., Krimsky, I., Maayan, M.L., Fani, K., and Jemenez, F.A.adipocyte size and number. Staining of the sections was performed
(1977). Gold thioglucose obesity syndrome. Fed. Proc. 36, 143–147.with hematoxylin/eosin. For each genotype and gender at least ten
DeFronzo, R.A. (1997). Pathogenesis of type 2 diabetes: metabolicfields (representing approximately 100 adipocytes) per slide were
and molecular implications for identifying diabetes genes. Diabetesanalyzed. Images were acquired using BX60 microscope (Olympus)
Rev. 5, 177–269.and an HV-C20 TV camera (Hitachi) and were analyzed using Image-
Pro Plus 4.0 software. Etherton, T.D., Thompson, E.H., and Allen, C.E. (1977). Improved
techniques for studies of adipocyte cellularity and metabolism. J.
Statistical Analyses Lipid Res. 18, 552–557.
All values are expressed as meanSEM unless otherwise indicated. Etherton, T.D., Aberle, E.D., Thompson, E.H., and Allen, C.E. (1981).
Statistical analyses were carried out using two-tailed Student’s un- Effects of cell size and animal age on glucose metabolism in pig
paired t test and among more than two groups by analysis of vari- adipose tissue. J. Lipid Res. 22, 72–80.
ance (ANOVA). Significance was rejected at p  0.05. Regression
Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M., and Paschke,analyses were performed to evaluate the relation between leptin
R. (2002). Hormonal regulation of adiponectin gene expression inserum levels, body weight, and fat pad mass.
3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 25, 1084–
1089.
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